The Price Target For GeoVax Labs Inc. (GOVX)?

0
21
TMC
TMC

GeoVax Labs Inc. (NASDAQ:GOVX) finished Wednesday with an addition of $0.01 to close at $1.09, an upside of 0.93 percent. An average of 2,331,240 shares of common stock have been traded in the last five days. There was a fall of -$0.3700 in the past week, and it reached a new high 6 times over the past 12 months. The last 20 days have seen an average of 6,634,660 shares traded, while the 50-day average volume stands at 27,222,061.

GOVX stock has decreased by -36.63% in the last month. The company shares reached their 1-month lowest point of $1.0300 on 09/07/22. With the stock rallying to its 52-week high on 08/01/22, shares of the company touched a low of $0.55 and a high of $5.61 in 52 weeks. It has reached a new high 2 times so far this year and lost -69.89% or -$2.5300 in price. In spite of this, the price is down -80.57% from the 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored


Valuation Metrics

GeoVax Labs Inc. (GOVX) stock’s beta is 3.25. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 107.73, the price-to-book (PB) ratio at 0.50.

Financial Health

The quick ratio of GeoVax Labs Inc. for the three months ended March 30 was 9.50, and the current ratio was 9.50, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending March 30. Its gross profit as reported stood at $19.13 million compared to revenue of $0.39 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, GeoVax Labs Inc.’s return on assets was -101.50%.

Earnings Surprise

The company posted a net income of -$2.24 million in the quarter, while revenues of -$2.43 million were grew 41.52%. The analyst consensus anticipated GeoVax Labs Inc.’s latest quarter earnings to come in at -$0.31 per share, but it turned out to be -$0.34, a -9.70% surprise. For the quarter, EBITDA amounted to -$2.23 million. At the end of the quarter ending March 30, GeoVax Labs Inc.’s stock balance sheet showed total liabilities of 5.37 million. Shareholders own equity worth $24.74 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at GeoVax Labs Inc. (GOVX) price momentum. RSI 9-day as of the close on 21 September was 36.82%, suggesting the stock is Neutral, with historical volatility in this time frame at 265.70%.

As of today, GOVX’s price is $1.1920 -25.34% or -$0.3700 from its 5-day moving average. GOVX is currently trading -35.50% lower than its 20-day SMA and +33.33% higher than its 100-day SMA. However, the stock’s current price level is +41.74% above the SMA50 and -70.46% below the SMA200.

The stochastic %K and %D were 13.82% and 19.51%, respectively, and the average true range (ATR) was 0.2272. With the 14-day stochastic at 7.32% and the average true range at 0.2615, the RSI (14) stands at 39.68%. The stock has reached -0.2100 on the 9-day MACD Oscillator while the 14-day reading was at -0.1245.

Analyst Ratings

Maxim Group launched coverage on GeoVax Labs Inc. (NASDAQ: GOVX) in its analyst report released on November 19, 2020. The firm assigned the stock a Buy rating. The consensus rating for GeoVax Labs Inc. (GOVX) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell GOVX, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here